These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17873215)

  • 1. Appropriate pharmacokinetic index for outcome in Staphylococcus aureus pneumonia.
    Potoski BA; Paterson DL
    Chest; 2007 Sep; 132(3):1101-2; author reply 1102-3. PubMed ID: 17873215
    [No Abstract]   [Full Text] [Related]  

  • 2. Methicillin-resistant Staphylococcus aureus pneumonia treatment: do not confuse pharmacokinetics and pharmacodynamics.
    Moine P; Bédos JP
    Chest; 2007 Sep; 132(3):1101, author reply 1102-3. PubMed ID: 17873216
    [No Abstract]   [Full Text] [Related]  

  • 3. Vancomycin dosing for methicillin-resistant staphylococcus aureus nosocomial pneumonia.
    Hall RG; Adams-Huet B
    Chest; 2007 Sep; 132(3):1100-1; author reply 1102-3. PubMed ID: 17873214
    [No Abstract]   [Full Text] [Related]  

  • 4. Optimal therapy for methicillin-resistant Staphylococcus aureus pneumonia: what is the best dosing regimen?
    Rello J; Mallol J
    Chest; 2006 Oct; 130(4):938-40. PubMed ID: 17035421
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
    Estes L; Orenstem R
    Clin Ther; 2007 Apr; 29(4):759-60; author reply 760-1. PubMed ID: 17617300
    [No Abstract]   [Full Text] [Related]  

  • 6. Potential impact of vancomycin pulmonary distribution on treatment outcomes in patients with methicillin-resistant Staphylococcus aureus pneumonia.
    Scheetz MH; Wunderink RG; Postelnick MJ; Noskin GA
    Pharmacotherapy; 2006 Apr; 26(4):539-50. PubMed ID: 16553514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What does it mean: appropriate therapy for methicillin-resistant Staphylococcus aureus?
    Viale P; Pea F
    Crit Care Med; 2007 Mar; 35(3):991; author reply 991-2. PubMed ID: 17421115
    [No Abstract]   [Full Text] [Related]  

  • 8. Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices.
    Jeffres MN; Isakow W; Doherty JA; McKinnon PS; Ritchie DJ; Micek ST; Kollef MH
    Chest; 2006 Oct; 130(4):947-55. PubMed ID: 17035423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linezolid and vancomycin for methicillin-resistant Staphylococcus aureus nosocomial pneumonia: the subtleties of subgroup analyses.
    Powers JH; Ross DB; Lin D; Soreth J
    Chest; 2004 Jul; 126(1):314-5; author reply 315-6. PubMed ID: 15249482
    [No Abstract]   [Full Text] [Related]  

  • 10. Vancomycin, unbeatable for methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia? Really?
    Luna CM; Bruno D; Aruj P
    Crit Care Med; 2010 Sep; 38(9):1910-2. PubMed ID: 20724890
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
    Estes L; Orenstein R
    Clin Ther; 2007 Feb; 29(2):381-3; author reply 383-4. PubMed ID: 17472831
    [No Abstract]   [Full Text] [Related]  

  • 12. Methicillin-resistant Staphylococcus aureus pneumonia after thoracic surgery: successful treatment with linezolid after failed vancomycin therapy.
    Salerno D; Vahid B; Marik PE
    Ann Thorac Surg; 2007 May; 83(5):1888-91. PubMed ID: 17462428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus.
    Maclayton DO; Hall RG
    Ann Pharmacother; 2007 Feb; 41(2):235-44. PubMed ID: 17299012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin versus linezolid in the treatment of methicillin-resistant Staphylococcus aureus nosocomial pneumonia: implications of the ZEPHyR trial.
    Alaniz C; Pogue JM
    Ann Pharmacother; 2012 Oct; 46(10):1432-5. PubMed ID: 22947593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia.
    Wunderink RG; Rello J; Cammarata SK; Croos-Dabrera RV; Kollef MH
    Chest; 2003 Nov; 124(5):1789-97. PubMed ID: 14605050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia.
    Jeffres MN; Isakow W; Doherty JA; Micek ST; Kollef MH
    Clin Ther; 2007 Jun; 29(6):1107-15. PubMed ID: 17692725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRSA pneumonia: better outcome through continuous infusion of vancomycin?
    Blot S
    Crit Care Med; 2005 Sep; 33(9):2127-8. PubMed ID: 16148496
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of hospital-acquired pneumonia caused by methicillin-resistant Staphylococcus aureus.
    Ferrara AM
    Int J Antimicrob Agents; 2007 Jul; 30(1):19-24. PubMed ID: 17475449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staphylococcus aureus pneumonia: a "superbug" infection in community and hospital settings.
    Kollef MH; Micek ST
    Chest; 2005 Sep; 128(3):1093-7. PubMed ID: 16162690
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hospital-acquired pneumonia caused by methicillin-resistant Staphylococcus aureus].
    Koulenti D; Myrianthefs P; Dimopoulos G; Baltopoulos G
    Enferm Infecc Microbiol Clin; 2005 Dec; 23 Suppl 3():37-45. PubMed ID: 16854340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.